KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Other financing activities: 2011-2014

Historic Other financing activities for Biocryst Pharmaceuticals (BCRX) over the last 1 years, with Jun 2014 value amounting to -$1.2 million.

  • Biocryst Pharmaceuticals' Other financing activities fell 533.33% to -$1.2 million in Q2 2014 from the same period last year, while for Jun 2014 it was -$300,000, marking a year-over-year decrease of 101.83%. This contributed to the annual value of $11.1 million for FY2023, which is N/A change from last year.
  • Per Biocryst Pharmaceuticals' latest filing, its Other financing activities stood at -$1.2 million for Q2 2014, which was up 23.53% from -$1.5 million recorded in Q1 2014.
  • In the past 5 years, Biocryst Pharmaceuticals' Other financing activities ranged from a high of $16.1 million in Q4 2012 and a low of -$3.6 million during Q4 2011.
  • For the 3-year period, Biocryst Pharmaceuticals' Other financing activities averaged around $2.0 million, with its median value being $390,000 (2013).
  • Examining YoY changes over the last 5 years, Biocryst Pharmaceuticals' Other financing activities showed a top increase of 550.78% in 2012 and a maximum decrease of 11,871.43% in 2012.
  • Quarterly analysis of 4 years shows Biocryst Pharmaceuticals' Other financing activities stood at -$3.6 million in 2011, then soared by 550.78% to $16.1 million in 2012, then plummeted by 88.27% to $1.9 million in 2013, then crashed by 533.33% to -$1.2 million in 2014.
  • Its Other financing activities stands at -$1.2 million for Q2 2014, versus -$1.5 million for Q1 2014 and $1.9 million for Q4 2013.